CD44 and breast carcinoma: This includes quartz crystal microbalance-based sensor5 and magnetic-fluorescent iron oxide–carbon hybrid nanoparticles6 and colorimetric nanobiosensor7 for the detection of CD44+ breast cancer cells, functionalized interdigitated electrodes for prostate cancer cells expressing CD448, functionalized stainless steel wire to capture breast CSC9 among others.